Mastering Competitiveness in Pharma | By Trilations

Jeremy Padbury, Global Commercial Strategy Director Oncology at GSK, joins Mastering Competitiveness to talk about execution, and why it matters more than ever. He shares how clear goals, aligned KPIs, and true global-to-local collaboration can help teams execute with confidence. The conversation dives into why competitiveness is a true team sport and how cross-functional collaboration enables faster adaptation and stronger global-to-local alignment.

This episode covers:

• How to benchmark performance beyond traditional KPIs
• How to use common language, metrics, and team alignment
• Why cross-functional collaboration is the real “secret sauce”
• How to make global-to-local collaboration an enabler, not a barrier
• How simplicity, humility, and communication drive better execution
• How to adapt in a fast-changing landscape

Annie Curti, Director and Launch Excellence Lead at Novartis, brings over 15 years of experience in life sciences consulting and biopharma leadership. In this episode of Mastering Competitiveness, she shares what it takes to launch successfully in today’s complex pharma environment: from aligning cross-functional teams to defining the right success metrics and keeping patient needs at the center.

We discuss how launch teams can stay agile, balance global and local dynamics, and go beyond clinical differentiation to compete effectively from day one.

In this episode, we explore:

(03:37) How the healthcare stakeholder landscape is evolving

(08:08) Overcoming cross-functional collaboration challenges

(10:38) Reinventing the company with customer focus

(13:19) Enhancing patient-centric communication

(18:02) Exploring non-clinical competitive advantages

(20:20) Data-driven strategy and execution

(21:07) Competitiveness in pharma over the next 10 to 15 years

Koen Union, Global Head of Market Research & Insights at UCB Biopharma, joins Trilations' CEO Johan Vermeiren and COO Claire Versluys to discuss how pharma insights teams can drive business impact through benchmarking, AI, and global-to-local planning.

How can pharma companies stay competitive in a saturated market? In this episode, Tim Talomie, VP Oncology Global Marketing at Merck, shares insights on building a differentiated commercial strategy and aligning teams for impact.

What you'll learn:

• How to define value beyond clinical efficacy
• The importance of understanding key stakeholders: HCPs, payers, regulators, and patients
• Why cross-functional collaboration is essential for success
• How to align global and local teams for seamless execution

Listen now and explore strategies for commercial success in pharma.

Follow Mastering Competitiveness for more insights from industry leaders.

How can medical affairs be a key driver of competitiveness rather than just a support function? In this first episode, Paul Burton, Chief Medical Officer at Amgen, discusses the evolving role of medical strategy in shaping corporate competitiveness.

What you'll learn:

• How medical affairs can drive competitive success
• Why benchmarking in medical strategy is complex—and how to do it right
• The growing importance of patient-centricity in pharma strategy
• How global-to-local execution ensures competitive impact
• Listen now to learn how leading medical affairs teams define success and drive impact

Follow Mastering Competitiveness for more insights from industry leaders.